0001179110-16-030045.txt : 20160927
0001179110-16-030045.hdr.sgml : 20160927
20160927162437
ACCESSION NUMBER: 0001179110-16-030045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160927
FILED AS OF DATE: 20160927
DATE AS OF CHANGE: 20160927
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Almstead Neil Gregory
CENTRAL INDEX KEY: 0001578850
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 161904672
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
4
1
edgar.xml
FORM 4 -
X0306
4
2016-09-27
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001578850
Almstead Neil Gregory
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
0
1
0
0
EVP Research Pharma Ops & Tech
Common Stock
2016-09-27
4
M
0
3414
10.85
A
3414
D
Common Stock
2016-09-27
4
M
0
6586
10.85
A
10000
D
Common Stock
1295
I
By spouse
Stock Option (Right to Buy)
10.85
2016-09-27
4
M
0
3414
10.85
D
2023-05-15
Common Stock
3414
66898
D
Stock Option (Right to Buy)
10.85
2016-09-27
4
M
0
6586
10.85
D
2023-05-15
Common Stock
6586
3102
D
Stock Option (Right to Buy)
27.05
2024-01-27
Common Stock
40000
40000
D
Stock Option (Right to Buy)
51.00
2025-01-01
Common Stock
69550
69550
D
Stock Option (Right to Buy)
30.86
2026-01-03
Common Stock
55000
55000
D
Stock Option (Right to Buy)
218.4
2022-01-10
Common Stock
166
166
D
Stock Option (Right to Buy)
490.8
2021-04-27
Common Stock
216
216
D
Stock Option (Right to Buy)
1149.6
2020-02-02
Common Stock
200
200
D
Stock Option (Right to Buy)
451.2
2019-05-15
Common Stock
200
200
D
Stock Option (Right to Buy)
735.6
2018-04-01
Common Stock
194
194
D
Stock Option (Right to Buy)
735.6
2018-01-25
Common Stock
166
166
D
Stock Option (Right to Buy)
626.4
2017-04-18
Common Stock
137
137
D
Stock Option (Right to Buy)
10.85
2023-05-15
Common Stock
600
600
I
By spouse
Stock Option (Right to Buy)
27.05
2024-01-27
Common Stock
1300
1300
I
By spouse
Stock Option (Right to Buy)
51.00
2025-01-01
Common Stock
2060
2060
I
By spouse
Restricted Stock Unit
Common Stock
750
750
I
By spouse
Stock Option (Right to Buy)
218.4
2022-01-10
Common Stock
7
7
I
By spouse
Stock Option (Right to Buy)
490.8
2021-04-27
Common Stock
7
7
I
By spouse
Stock Option (Right to Buy)
1149.6
2020-02-02
Common Stock
1
1
I
By spouse
Stock Option (Right to Buy)
508.8
2019-10-07
Common Stock
12
12
I
By spouse
This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on June 15, 2014.
This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on January 31, 2014.
This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
This restricted stock unit (RSU) award was granted on January 4, 2016 and vests in equal installments over four years on each anniversary of the grant date. Upon vesting, each RSU will convert into one share of common stock of the Issuer.
Currently exercisable.
/s/ Colleen Diver Johnson, attorney-in-fact
2016-09-27